• Street Talk

Devices stock ImpediMed seeks funds for trials

Canaccord Genuity and Wilsons are in the market with an equity raising for ImpediMed. 

• Jun 25, 2019
• Sarah Thompson and Anthony Macdonald

• Iron ore

Fortescue Metals appoints Elizabeth Gaines as CFO

Andrew 'Twiggy' Forrest's miner Fortescue Metals has appointed former travel industry executive Elizabeth Gaines as its CFO.

• Updated Jan 17, 2017
• Tess Ingram and Jessica Gardner

ImpediMed moves into the home to help hospitals avoid penalties

ImpediMed's new focus on heart failure puts it at the apex of two huge shifts occurring in healthcare.

• Updated Jan 10, 2017
• Jessica Gardner

Biotech stocks to get the heart racing … or slowing

Notoriously volatile and tricky to pick, biotechnology stocks gave nimble investors plenty of opportunity to outperform blue chips in 2015 and are set to provide some wild rides in 2016 too.

• Updated Jan 7, 2016
• Jessica Sier

Back from the brink, ImpediMed gears up for US launch

There was a time when ImpediMed chief executive Rick Carreon thought the medical device maker might not survive. A quintupling in the share price in the past 16 months is reassuring.

• Updated Nov 16, 2015
• Tim Binsted

• Pharmaceuticals

Low Aussie dollar could spur biotech takeovers

A string of high-profile setbacks may have whittled away support for biotechnology companies, but executives and analysts say there is still plenty of money from overseas and the weak Australian dollar may spur a series of takeovers by foreign buyers.

• Updated Jan 12, 2015
• Jessica Gardner

Biotechnology stocks to watch in 2015

After a disappointing year for biotech stocks, in which a number of heavyweights faltered on the back of poor clinical results or internal blunders, investors are scouring the sector for the next big thing.

• Updated Jan 1, 2015
• Jessica Gardner

ImpediMed shares soar 93pc on US funding

Shares in medical device maker ImpediMed soared 93 per cent higher after the company announced that the main funders of public healthcare in the US agreed to a higher-than-anticipated level of reimbursement.

• Updated Nov 3, 2014
• Jessica Gardner

• Hospitals

How to pick the next hot biotechnology stock

It’s a harsh but true assessment that many investors don’t understand biotechnology. So what hope is there for retail investors to profit from the next wonder drug?

• Updated Apr 11, 2014
• Jessica Gardner

Results Wrap | Australian Vintage profit up

Reporting season live | Globe International profit surges, Austin dives 95pc, Mayne Pharma and Wilson HTM in the black; Mesoblast loss widens; Regional Express has $5m profit.

• Updated Feb 26, 2014
• Sineva Toevai

• Street Talk

ImpediMed eyes $13.7m raising

Medical devices company ImpediMed is seeking to raise $13.7 million in an entitlement offer through Wilson HTM and RBS Morgans.

• May 1, 2012
• Sarah Thompson and Anthony Macdonald

Minnows poised for greatness

It may be only a matter of time before animal spirits return to the market following a strong rebound in sentiment since the outbreak of violence in the Arab world and the disaster in Japan.

• Updated Mar 30, 2011
• Brendon Lau

• Market Wrap

Animal spirits to seek minnows with mojo

It may be only a matter of time before animal spirits return to the market and minnows with the potential to increase their market value in multiples are likely to gain investor attention.

• Updated Mar 30, 2011
• Brendon Lau

• Street Talk

ImpediMed seeks $20m to expand in the US

Medical device maker ImpediMed is understood to be sounding out shareholders about a $20 million capital raising as it expands its foothold in the US.

• Updated Dec 2, 2010
• Sarah Thompson and Khia Mercer

Company briefs

Finders Resources has raised $20.95 million through Blackswan Equities to progress the first stage of its Wetar copper project in Indonesia.

• Aug 31, 2010